Hermetica Superfood Encyclopedia
The Short Answer
Achyrocline satureioides contains flavonoid aglycones — primarily quercetin, luteolin, 3-O-methylquercetin, and achyrobichalcone — that exert anti-inflammatory effects by inhibiting TLR-4 signaling, suppressing adhesion molecules, and blocking chemotactic mediators such as CINC-1 and leukotriene B4. In rodent models, an oral hydroalcoholic extract at 100 mg/kg significantly reduced LPS-induced neutrophil migration and β2-integrin/L-selectin expression without detectable systemic toxicity, though equivalent human clinical data remains absent.
CategoryHerb
GroupAmazonian
Evidence LevelPreliminary
Primary KeywordAchyrocline satureioides benefits
Wira Wira — botanical close-up
Health Benefits
**Anti-Inflammatory Activity**
Flavonoid aglycones including quercetin and luteolin suppress neutrophil recruitment by downregulating TLR-4 expression and reducing CINC-1 and leukotriene B4 secretion in inflammatory exudates, targeting multiple points in the innate immune cascade.
**Antioxidant Protection**
Ethanolic extracts of the inflorescences demonstrate antioxidant capacity of 6.62–15.15 mMol Trolox equivalent per 100 g dry weight (TEAC assay), with flavonoid concentrations up to 132 mg/g in freeze-dried hydroethanol extracts, suggesting meaningful free radical scavenging potential.
**Antimicrobial Defense**
The plant's phytochemical constituents have demonstrated in vitro inhibitory activity against both gram-positive bacteria (Staphylococcus aureus, Staphylococcus epidermidis) and gram-negative bacteria (Escherichia coli), as well as against Lactobacillus acidophilus, indicating broad-spectrum antimicrobial capacity.
**Neutrophil Function Modulation**
Beyond receptor-level inhibition, the hydroalcoholic extract suppresses direct intracellular protein kinase activation in neutrophils, suggesting a multi-layered mechanism that attenuates excessive innate immune responses implicated in chronic inflammatory conditions.
**Adhesion Molecule Suppression**
At 100 mg/kg in rat models, the extract reduced the proportion of β2-integrin-positive and L-selectin-positive neutrophils following LPS challenge, thereby limiting the extravasation of immune cells into inflamed tissues and reducing localized tissue damage.
**Traditional Immunomodulatory Use**
Indigenous communities including the Ilipana Yuyo have used this herb to manage inflammatory conditions, a practice that aligns mechanistically with the observed modulation of the innate immune response documented in preclinical research.
Origin & History
Natural habitat
Achyrocline satureioides is a flowering herb native to South America, distributed widely across Brazil, Uruguay, Argentina, Paraguay, and the Andean regions of Bolivia and Peru. It thrives in open grasslands, roadsides, and disturbed soils at varying altitudes, favoring warm to temperate climates with moderate rainfall. The plant's inflorescences — its primary medicinal part — are harvested at peak bloom and have been cultivated and gathered by indigenous communities, including the Ilipana Yuyo of the Amazonian region, for generations.
“Achyrocline satureioides, commonly called 'marcela' or 'wira wira' across South America, holds deep ethnobotanical significance in indigenous and rural communities spanning Argentina, Uruguay, Brazil, Bolivia, and Peru, where it has been used for centuries as a primary remedy for digestive ailments, fever, and inflammatory conditions. In the Andean tradition, it is among the most widely consumed medicinal herbs, prepared as a hot infusion of the dried golden-yellow inflorescences, often consumed after meals as a carminative and anti-inflammatory digestive tonic. The Ilipana Yuyo community of the Amazonian region incorporates the plant into their traditional herbal pharmacopeia, reflecting its cross-cultural relevance across both highland Andean and lowland Amazonian indigenous health systems. The plant's common name 'marcela' derives from regional Spanish nomenclature, while 'wira wira' reflects Quechua linguistic tradition, underscoring its pre-colonial indigenous origins and continued relevance in contemporary ethnomedicine.”Traditional Medicine
Scientific Research
The evidence base for Achyrocline satureioides consists entirely of in vitro studies and animal model experiments, with no published human clinical trials identified in the current literature. The most controlled preclinical evidence comes from rodent studies using male Wistar rats administered oral hydroalcoholic extract at 100 mg/kg, demonstrating measurable reductions in LPS-induced neutrophil migration and adhesion molecule expression without systemic toxicity. Phytochemical characterization studies have quantified flavonoid content across multiple extraction methods, providing reproducible concentration data (e.g., 132 mg/g in freeze-dried hydroethanol extracts), adding analytical rigor to compound identification. The overall evidence quality is preliminary: while mechanistic consistency between in vitro and animal findings is encouraging, the absence of human pharmacokinetic, efficacy, and safety data represents a critical gap that prevents definitive clinical recommendations.
Preparation & Dosage
Traditional preparation
**Traditional Infusion (Tea)**
Dried inflorescences of Achyrocline satureioides are steeped in hot water; no standardized human dose has been established from clinical trials, but traditional use in South America involves daily consumption of infusions made from the aerial flowering parts.
**Hydroalcoholic Extract**
100 mg/kg in rats; human equivalent dosing has not been validated and cannot be reliably calculated without pharmacokinetic bridging studies
Used in preclinical research at .
**Freeze-Dried Hydroethanol Extract**
132 mg flavonoids per gram; this high-concentration form is used in laboratory research and may be the most pharmacologically potent format, though no standardized commercial supplement dose exists
Contains approximately .
**Spray-Dried Hydroethanol Extract**
7 mg flavonoids per gram, nearly equivalent to freeze-dried preparations, and represents a commercially scalable form
Contains approximately 129..
**Aqueous (Water) Extract**
23 mg/g freeze-dried), reflecting the lower water solubility of flavonoid aglycones relative to hydroalcoholic solvents
Yields lower flavonoid concentrations (~54..
**Standardization Note**
No pharmacopeial or regulatory standard for quercetin or total flavonoid content in Achyrocline satureioides supplements currently exists; consumers should exercise caution with commercial products lacking third-party certificate of analysis.
Nutritional Profile
Achyrocline satureioides is not consumed as a macronutrient-significant food source; its nutritional relevance lies primarily in its dense phytochemical composition. The inflorescences contain high concentrations of flavonoid aglycones, quantified at up to 132 mg/g in optimized extracts, with key compounds being quercetin, luteolin, 3-O-methylquercetin, and the chalcone achyrobichalcone. Antioxidant capacity measured by TEAC assay ranges from 3.91 mMol Trolox equivalent per 100 g dry weight (aqueous infusion) to 15.15 mMol Trolox equivalent per 100 g (ethanolic extract, extended extraction). Heavy metal analysis confirms the plant is within safe limits for lead (0.35–0.38 mg/kg), cadmium (0.09–0.10 mg/kg), and chromium (0.45–0.62 mg/kg), though fluoride content at 17.0 mg/kg warrants attention with high-volume long-term consumption. The bioavailability of the aglycone flavonoids — particularly quercetin — is generally moderate in humans and influenced by gut microbiota metabolism, food matrix effects, and formulation type.
How It Works
Mechanism of Action
The primary anti-inflammatory mechanism of Achyrocline satureioides centers on inhibition of the TLR-4 signaling pathway: the hydroalcoholic extract reduces TLR-4 receptor expression on neutrophils, blunting the initial recognition of lipopolysaccharide and limiting downstream pro-inflammatory cascades. The flavonoid aglycones quercetin and luteolin further suppress secretion of CINC-1 (cytokine-induced neutrophil chemoattractant-1) and leukotriene B4, two potent chemotactic mediators that drive neutrophil migration into sites of inflammation. Additionally, the extract inhibits intracellular protein kinase activity independent of TLR-4 engagement, suggesting that achyrobichalcone and methylated flavonoids may interfere with downstream kinase signaling nodes such as PKC or MAPK pathways. The antimicrobial activity is attributed to the combined action of these polyphenolic compounds disrupting bacterial membrane integrity and inhibiting key metabolic enzymes across both gram-positive and gram-negative species.
Clinical Evidence
No human clinical trials for Achyrocline satureioides have been identified in the peer-reviewed literature as of this writing, meaning there are no reported sample sizes, effect sizes, or controlled outcome measurements in human populations. Preclinical evidence from rodent models provides the strongest available mechanistic data, demonstrating significant attenuation of LPS-induced neutrophil migration and reduced expression of pro-inflammatory adhesion markers at an oral dose of 100 mg/kg. Analytical chemistry studies confirm consistent flavonoid delivery across extraction formats, lending credibility to the bioactive hypothesis, but bioavailability and pharmacokinetic profiles in humans are entirely uncharacterized. Confidence in clinical applicability remains low; results from animal models should not be extrapolated to human dosing or therapeutic outcomes until well-designed Phase I and Phase II trials are conducted.
Safety & Interactions
Animal studies using oral hydroalcoholic extract of Achyrocline satureioides at doses of 100 mg/kg in Wistar rats have not produced observable systemic toxicity, representing a favorable preliminary safety signal, though this cannot be directly translated to human safety without clinical trial data. Heavy metal contamination analysis shows values below internationally recognized harmful thresholds for lead, cadmium, and chromium, suggesting that properly sourced material carries low heavy metal risk. No human adverse effect data, drug interaction profiles, or contraindication records are available in the peer-reviewed literature; given the plant's flavonoid content — particularly quercetin — theoretical interactions with anticoagulants (e.g., warfarin), cytochrome P450 substrates, and thyroid medications cannot be excluded and warrant clinical scrutiny. Pregnancy and lactation safety has not been studied, and in keeping with standard precautionary principles for unstudied botanicals, use during pregnancy or breastfeeding should be avoided until evidence-based guidance is established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Achyrocline satureioidesMarcelaWira WiraMacelaVira-viraYerba de la vida
Frequently Asked Questions
What is Achyrocline satureioides used for traditionally?
Achyrocline satureioides, known regionally as marcela or wira wira, has been used for centuries in South American traditional medicine primarily to treat inflammatory conditions, digestive complaints, fever, and as a general tonic. Indigenous communities including the Ilipana Yuyo of the Amazon and Andean populations prepare the dried golden inflorescences as a hot water infusion consumed daily. These traditional uses are increasingly supported by preclinical laboratory evidence showing inhibition of key inflammatory mediators such as leukotriene B4 and CINC-1.
What are the active compounds in Achyrocline satureioides?
The primary bioactive compounds in Achyrocline satureioides are flavonoid aglycones, specifically quercetin, luteolin, 3-O-methylquercetin, and a chalcone called achyrobichalcone. Flavonoid concentrations vary significantly by extraction method, ranging from approximately 54 mg/g in aqueous extracts to 132 mg/g in freeze-dried hydroethanol extracts. These compounds are responsible for the plant's demonstrated anti-inflammatory, antioxidant, and antimicrobial activities in laboratory and animal studies.
Are there human clinical trials on Achyrocline satureioides?
As of the current literature, no human clinical trials have been published for Achyrocline satureioides, which is a significant limitation in assessing its clinical efficacy and safety. The available evidence consists of in vitro cell studies and animal experiments — most notably rat models where a 100 mg/kg oral dose reduced neutrophil-driven inflammation without systemic toxicity. Until randomized controlled trials in humans are conducted, all findings remain preliminary and should not be used to guide medical treatment decisions.
Is Achyrocline satureioides safe to consume?
Animal studies have not revealed systemic toxicity from hydroalcoholic extracts of Achyrocline satureioides at experimentally tested doses, and heavy metal analysis of the plant material shows levels of lead, cadmium, and chromium well below international safety thresholds. However, no human safety data, adverse event reporting, or drug interaction studies are available, meaning potential interactions with medications such as anticoagulants or CYP450-metabolized drugs cannot be ruled out. Pregnant and breastfeeding individuals should avoid use until safety data in humans is established.
How does Achyrocline satureioides reduce inflammation?
Achyrocline satureioides reduces inflammation through at least three distinct mechanisms: it downregulates TLR-4 receptor expression on neutrophils, inhibits secretion of the chemotactic mediators CINC-1 and leukotriene B4, and suppresses intracellular protein kinase signaling independently of TLR-4 activation. These combined actions reduce the recruitment and activation of neutrophils at sites of inflammation, limiting tissue damage from excessive innate immune responses. The flavonoids quercetin and luteolin are considered the principal compounds responsible for these effects based on their known pharmacological targets.
Does Wira Wira (Achyrocline satureioides) interact with common anti-inflammatory medications?
Wira Wira contains flavonoid compounds that work through similar immune-modulating pathways as some pharmaceutical anti-inflammatories, particularly those targeting TLR-4 signaling. Concurrent use with NSAIDs, corticosteroids, or immunosuppressants may potentiate effects and should be discussed with a healthcare provider. There are no well-documented serious drug interactions, but additive effects on inflammatory markers warrant medical oversight.
What is the most effective form of Achyrocline satureioides for anti-inflammatory benefits?
Ethanolic extracts of the inflorescences (flowers) demonstrate the highest antioxidant capacity (6.62–15 units measured) and contain concentrated flavonoid aglycones like quercetin and luteolin responsible for neutrophil suppression. Standardized herbal extracts tend to be more effective than whole dried herb preparations due to concentrated active compound levels. Traditional tea or infusion preparations are less potent than pharmaceutical-grade extracts but remain commonly used in South American traditional medicine.
Who should avoid taking Wira Wira supplements?
Individuals with bleeding disorders or taking anticoagulant medications should exercise caution, as quercetin and luteolin may have mild antiplatelet properties. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data in these populations. People with severe immunosuppression should consult healthcare providers before use, as the herb's immune-modulating effects may be unpredictable in compromised immune states.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w wira-wira-achyrocline-satureioides curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
